GE
Generate Biomedicines, Inc. (GENB)
NASDAQ·Financial Services·Asset Management
$12.28
-5.04%
Mkt Cap $1.69B
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (1 analysts)
$25.00
Range $25.00 – $25.00
Implied Upside
+103.6%
Consensus $25.00 vs current $12.28